Adjuvant potential of selegiline in treating acute toxicity of aluminium phosphide in rats.
Aluminum Compounds
/ poisoning
Animals
Antidotes
/ administration & dosage
Disease Models, Animal
Drug Evaluation, Preclinical
Duodenum
/ drug effects
Heart
/ drug effects
Humans
Injections, Intraperitoneal
Male
Membrane Potential, Mitochondrial
/ drug effects
Mitochondria
/ drug effects
Myocardium
/ pathology
Oxidative Stress
/ drug effects
Pesticides
/ poisoning
Phosphines
/ poisoning
Poisoning
/ drug therapy
Rats
Reactive Oxygen Species
/ metabolism
Selegiline
/ administration & dosage
Stomach
/ drug effects
Treatment Outcome
aluminium phosphide
cardiac toxicity
mitochondria
rat
selegiline
Journal
Basic & clinical pharmacology & toxicology
ISSN: 1742-7843
Titre abrégé: Basic Clin Pharmacol Toxicol
Pays: England
ID NLM: 101208422
Informations de publication
Date de publication:
Jul 2019
Jul 2019
Historique:
received:
06
10
2018
accepted:
15
01
2019
pubmed:
4
2
2019
medline:
15
1
2020
entrez:
4
2
2019
Statut:
ppublish
Résumé
Aluminium phosphide (AlP) is a highly toxic substance with a high mortality rate and no effective antidote. Once exposed to the moisture and acidic conditions of the stomach, AlP releases toxic phosphine (PH
Substances chimiques
Aluminum Compounds
0
Antidotes
0
Pesticides
0
Phosphines
0
Reactive Oxygen Species
0
Selegiline
2K1V7GP655
aluminum phosphide
E23DR6L59S
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
62-74Subventions
Organisme : Tehran University of Medical Sciences (TUMS)
ID : 95-04-30-33411
Informations de copyright
© 2019 Nordic Association for the Publication of BCPT (former Nordic Pharmacological Society).